COGNITION THERAPEUTICS INC. - COMMON STOCK
0.4350
04-October-24 15:59:44
15 minutes delayed
Stocks
9.9999999999989E-05
+0.02%
Today's range
0.4300 - 0.4489
ISIN
N/A
Source
NASDAQ
-
15 Dec 2022 08:00:42 By Nasdaq GlobeNewswire
-
28 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series
21 Nov 2022 08:00:33 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Closing of Public Offering
15 Nov 2022 12:55:47 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
14 Nov 2022 08:00:07 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Pricing of Public Offering
10 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Appoints CNS Drug Development Expert to VP Clinical Development
11 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
29 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
27 Sep 2022 07:32:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Participation in September Investment Conferences
06 Sep 2022 07:32:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
09 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
04 Aug 2022 16:02:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
03 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
19 Jul 2022 08:00:02 By Nasdaq GlobeNewswire
-
23 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
08 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
02 Jun 2022 16:01:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Participate in H.C. Wainwright Global Investment Conference
13 May 2022 07:30:00 By Nasdaq GlobeNewswire